"We have been holding talks with experts of Indian Council of Medical Research (ICMR). Soon we may come out with a notification banning the use and sale of Rapid Card Test (RCT) used for detection of dengue as they are not reliable," Jagdish Prasad, Director General, Directorate General of Health Services (DGHS) told reporters here today.
The Union Health Ministry has also decided to seek reports from hospitals in Delhi including AIIMS, RML and Safdarjung to ensure that there is no "fudging" of dengue numbers reported in the national capital.
"We recommend ELISA based IgM kits provided by National Institute of Virology (NIV) at 499 Sentinel surveillance hospitals and 15 Apex Referral Laboratories to facilitate free diagnosis," Prasad said.
The official noted that Elisa method is "sensitive, specific and reliable" while rapid dengue antigen test or on-the-spot test which gives result in an hour, may provide false results and ultimately lead to inaccurate treatment.
In Elisa method, it takes six to seven hours for the results to come out. As per the guidelines of the National Vector Borne Disease Control Programme (NVBDCP), NS1 Elisa test is considered reliable for confirmation of dengue infection, he said.
"Since there have been allegations that the Delhi government is underplaying the dengue figures, I will seek reports from major individual hospitals," Prasad said.
According to the Ministry, in Delhi, the number of dengue cases reported this year till September 5 has reached 1,259 while two persons have succumbed to it.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
